A study in JAMA reported that the YEARS diagnostic algorithm can serve as a frontline approach for pulmonary embolism in cancer patients, achieving performance comparable to computed tomographic pulmonary angiography (CTPA). The report also indicates the algorithm reduces reliance on CTPA in more than one-fifth of cases. The clinical value is immediate: it shifts decision-making toward a less invasive pathway while maintaining diagnostic accuracy. For oncology care settings where imaging burden and risk-management are major issues, lowering unnecessary CTPA use can streamline workflows and reduce patient exposure. The key signal is the cancer-specific application—supporting algorithm-based PE triage in a population already at elevated thromboembolic risk.